Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04510506 · ClinicalTrials.gov registry record · NA
Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT04510506 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 42 participants.
The verdict
NCT04510506, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study designed to assess changes in control of Type 1 Diabetes in pubertal adolescents over a two year period. There are two arms/substudies, the first being a longitudinal randomized controlled trial and the second an observational study.
Interventions
- DEVICE Artificial Pancreas (AP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2025-10-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04510506
The ClinicalTrials.gov registry entry for NCT04510506 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Artificial Pancreas (AP) is the first listed.
NCT04510506 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04510506 about?
NCT04510506 is a clinical study titled "Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation". This study designed to assess changes in control of Type 1 Diabetes in pubertal adolescents over a two year period. There are two arms/substudies, the first being a longitudinal randomized controlled trial and the second an observational study.
What is the current status of trial NCT04510506?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2020-11-19. Estimated completion is 2025-10-24.
What interventions are being tested in trial NCT04510506?
The interventions under investigation include: Artificial Pancreas (AP) (DEVICE).
Who is sponsoring clinical trial NCT04510506?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.